RG2077
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RG2077, covering 2017-03-27 to 2017-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety of RG2077 in Patients With Multiple Sclerosis [Phase 1]